Korean Drug Co., Ltd. (KOSDAQ:014570)
4,040.00
-20.00 (-0.49%)
At close: Feb 13, 2026
Korean Drug Market Cap
Korean Drug has a market cap or net worth of 44.08 billion as of February 13, 2026. Its market cap has decreased by -17.47% in one year.
Market Cap
44.08B
Enterprise Value
15.13B
Revenue
62.21B
Ranking
n/a
PE Ratio
15.80
Stock Price
4,040.00
Market Cap Chart
Since March 31, 2005, Korean Drug's market cap has increased from 12.54B to 44.08B, an increase of 251.55%. That is a compound annual growth rate of 6.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 44.08B | -6.05% |
| Dec 30, 2025 | 46.92B | -6.42% |
| Dec 30, 2024 | 50.14B | -36.00% |
| Dec 28, 2023 | 78.35B | -8.30% |
| Dec 29, 2022 | 85.44B | -12.32% |
| Dec 30, 2021 | 97.44B | -13.30% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sinil Pharmaceutical | 68.03B |
| Jin Yang Pharmaceutical | 64.55B |
| Korea Arlico Pharm | 59.85B |
| RP Bio | 58.50B |
| Eagle Veterinary Technology Co.,Ltd | 55.43B |
| Kyung Nam Pharm | 47.75B |
| GeneBioTech Co. ,Ltd | 43.31B |
| HLscience | 41.71B |